Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
new option listings on November 25th » 08:30
11/25/20
11/25
08:30
11/25/20
08:30
ABIO

ARCA Biopharma

$4.04 /

-0.11 (-2.65%)

, AHCO

AdaptHealth

$28.87 /

-0.4 (-1.37%)

, DMTK

DermTech

$11.65 /

-0.3 (-2.51%)

, DRIV

Digital River

$22.11 /

+0.495 (+2.29%)

, EDOC

Applied Voice Recognition Inc

$17.82 /

-0.17 (-0.94%)

, EKSO

Ekso Bionics

$5.80 /

+0.56 (+10.69%)

, FAN

First Trust Global Wind Energy

$20.38 /

+0.06 (+0.30%)

, GP

GreenPower Motor

$25.60 /

-2.25 (-8.08%)

, KZIA

Kazia Therapeutics

$10.17 /

+0.62 (+6.49%)

, MSP

Datto

$25.97 /

-1.02 (-3.78%)

, QLGN

Qualigen Therapeutics

$3.31 /

-0.04 (-1.19%)

, ROOT

Root

$16.71 /

-0.335 (-1.97%)

, RVMD

Revolution Medicines

$41.58 /

+0.895 (+2.20%)

, TCON

Tracon Pharmaceuticals

$8.45 /

-0.55 (-6.11%)

New option listings for…

New option listings for November 25th include ARCA Biopharma (ABIO), AdaptHealth Corporation (Class A Stock) (AHCO), DermTech Inc (DMTK), Global X Autonomous and Electric Vehicles (DRIV), Direxion Daily Industrials Bull 3x Shares (DUSL), Global X E commerce ETF (EBIZ), Global X Telemedicine and Digital Health (EDOC), Ekso Bionics (EKSO), First Trust ISE Global Wind Energy Index Fund (FAN), Fidelity Low Volatility Factor ETF (FDLO), First Trust DJ Global Select Dividend Index Fund (FGD), GreenPower Motor Company Inc (GP), Direxion Daily South Korea Bull 3X Shares (KORU), Kazia Therapeutics Ltd (ADS) (KZIA), Datto Holding Corp (MSP), Qualigen Therapeutics Inc (QLGN), Root Inc (ROOT), Revolution Medicines Inc (RVMD), TRACON Pharmaceuticals (TCON), Direxion Daily Transportation Bull 3x Shares (TPOR), and WisdomTree Cloud Computing Fund (WCLD).

ShowHide Related Items >><<
TCON Tracon Pharmaceuticals
$8.45 /

-0.55 (-6.11%)

RVMD Revolution Medicines
$41.58 /

+0.895 (+2.20%)

ROOT Root
$16.71 /

-0.335 (-1.97%)

QLGN Qualigen Therapeutics
$3.31 /

-0.04 (-1.19%)

MSP Datto
$25.97 /

-1.02 (-3.78%)

KZIA Kazia Therapeutics
$10.17 /

+0.62 (+6.49%)

GP GreenPower Motor
$25.60 /

-2.25 (-8.08%)

EKSO Ekso Bionics
$5.80 /

+0.56 (+10.69%)

DMTK DermTech
$11.65 /

-0.3 (-2.51%)

AHCO AdaptHealth
$28.87 /

-0.4 (-1.37%)

ABIO ARCA Biopharma
$4.04 /

-0.11 (-2.65%)

ABIO ARCA Biopharma
$4.04 /

-0.11 (-2.65%)

AHCO AdaptHealth
$28.87 /

-0.4 (-1.37%)

11/17/20 Deutsche Bank
AdaptHealth price target raised to $36 from $26 at Deutsche Bank
11/16/20 Baird
AdaptHealth initiated with an Outperform at Baird
11/05/20 SVB Leerink
AdaptHealth price target raised to $32.50 from $23.50 at SVB Leerink
08/11/20 RBC Capital
AdaptHealth price target raised to $33 from $24 at RBC Capital
DMTK DermTech
$11.65 /

-0.3 (-2.51%)

10/29/20 William Blair
DermTech initiated with an Outperform at William Blair
09/11/20
Fly Intel: Top five analyst initiations
09/10/20 Brookline
DermTech initiated with a Buy at Brookline
09/10/20 Cowen
DermTech initiated with an Outperform at Cowen
DRIV Digital River
$22.11 /

+0.495 (+2.29%)

EDOC Applied Voice Recognition Inc
$17.82 /

-0.17 (-0.94%)

EKSO Ekso Bionics
$5.80 /

+0.56 (+10.69%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
FAN First Trust Global Wind Energy
$20.38 /

+0.06 (+0.30%)

GP GreenPower Motor
$25.60 /

-2.25 (-8.08%)

11/25/20 Maxim
GreenPower Motor price target raised to $35 from $22 at Maxim
11/19/20 BTIG
BTIG reiterates Buy rating on GreenPower Motor after investors meetings
11/02/20
Fly Intel: Top five analyst initiations
11/02/20 Maxim
GreenPower Motor initiated with a Buy at Maxim
KZIA Kazia Therapeutics
$10.17 /

+0.62 (+6.49%)

MSP Datto
$25.97 /

-1.02 (-3.78%)

11/17/20 Citi
Datto initiated with a Neutral at Citi
11/16/20 William Blair
Datto initiated with an Outperform at William Blair
11/16/20 Mizuho
Datto initiated with a Neutral at Mizuho
11/16/20 Morgan Stanley
Datto initiated with an Equal Weight at Morgan Stanley
QLGN Qualigen Therapeutics
$3.31 /

-0.04 (-1.19%)

08/25/20 Alliance Global Partners
Qualigen upgraded to Buy from Neutral at Alliance Global Partners
ROOT Root
$16.71 /

-0.335 (-1.97%)

11/23/20 Barclays
Root initiated with an Equal Weight at Barclays
11/23/20 Truist
Root initiated with a Buy at Truist
11/23/20 Cantor Fitzgerald
Root initiated with an Overweight at Cantor Fitzgerald
11/23/20 UBS
Root initiated with a Neutral at UBS
RVMD Revolution Medicines
$41.58 /

+0.895 (+2.20%)

10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
TCON Tracon Pharmaceuticals
$8.45 /

-0.55 (-6.11%)

09/17/20 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $7 from $4 at H.C. Wainwright
04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
TCON Tracon Pharmaceuticals
$8.45 /

-0.55 (-6.11%)

RVMD Revolution Medicines
$41.58 /

+0.895 (+2.20%)

QLGN Qualigen Therapeutics
$3.31 /

-0.04 (-1.19%)

MSP Datto
$25.97 /

-1.02 (-3.78%)

EKSO Ekso Bionics
$5.80 /

+0.56 (+10.69%)

DMTK DermTech
$11.65 /

-0.3 (-2.51%)

AHCO AdaptHealth
$28.87 /

-0.4 (-1.37%)

ABIO ARCA Biopharma
$4.04 /

-0.11 (-2.65%)

  • 28
    Oct
  • 21
    Oct
  • 03
    Sep
  • 09
    Jul
  • 01
    Jul
  • 13
    Feb
GP GreenPower Motor
$25.60 /

-2.25 (-8.08%)

RVMD Revolution Medicines
$41.58 /

+0.895 (+2.20%)

ROOT Root
$16.71 /

-0.335 (-1.97%)

MSP Datto
$25.97 /

-1.02 (-3.78%)

EKSO Ekso Bionics
$5.80 /

+0.56 (+10.69%)

Over a month ago
Hot Stocks
Ekso Bionics announces EGM Builders as first customer to adopt EVO tech » 08:30
10/29/20
10/29
08:30
10/29/20
08:30
EKSO

Ekso Bionics

$4.14 /

-0.23 (-5.26%)

Ekso Bionics Holdings…

Ekso Bionics Holdings announced that EGM Builders, a self-performing general contractor providing construction services in New Jersey and New York, is the first customer to acquire EVO units. Launched in August 2020, EVO is the Company's latest innovation in exoskeleton technology for industrial use.

ShowHide Related Items >><<
EKSO Ekso Bionics
$4.14 /

-0.23 (-5.26%)

EKSO Ekso Bionics
$4.14 /

-0.23 (-5.26%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
EKSO Ekso Bionics
$4.14 /

-0.23 (-5.26%)

EKSO Ekso Bionics
$4.14 /

-0.23 (-5.26%)

Over a quarter ago
Hot Stocks
Ekso Bionics unveils latest assistive exoskeleton for industrial use » 08:40
08/20/20
08/20
08:40
08/20/20
08:40
EKSO

Ekso Bionics

$5.38 /

-0.1 (-1.82%)

Ekso Bionics unveiled…

Ekso Bionics unveiled EVO, an endurance-boosting assistive upper body exoskeleton that alleviates the burden of repetitive work. Building on the Company's trailblazing EksoVest technology, EVO's innovative design is the next step in the evolution of industrial exoskeletons. Through collaborations with leaders in global manufacturing and construction, Ekso Bionics has accumulated a wealth of in-the-field customer insights that allowed it to reimagine its weight-assist exoskeleton technology. EVO is lighter and more flexible than its predecessor, with an optimized human-machine interface that is cool and comfortable to wear for all-day use, while also maintaining the ruggedness and durability that Ekso is known for. EVO's novel design also incorporates Ekso's new patented low profile, multi-link structure, which tracks the natural movement of the body and allows for an unrestricted range of motion, and a device architecture that is compatible with standard safety harnesses used in elevated work. These advancements in design make EVO the ideal solution for a wide range of industrial, manufacturing, food processing, and construction applications.

ShowHide Related Items >><<
EKSO Ekso Bionics
$5.38 /

-0.1 (-1.82%)

EKSO Ekso Bionics
$5.38 /

-0.1 (-1.82%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$5.38 /

-0.1 (-1.82%)

EKSO Ekso Bionics
$5.38 /

-0.1 (-1.82%)

Earnings
Ekso Bionics reports Q2 EPS ($1.88), consensus (55c) » 16:25
07/30/20
07/30
16:25
07/30/20
16:25
EKSO

Ekso Bionics

$7.36 /

-0.03 (-0.41%)

Reports Q2 revenue $2.3M,…

Reports Q2 revenue $2.3M, consensus $1.62M. We are pleased with our team's strong execution in navigating through an extraordinarily difficult environment," said Jack Peurach, President and Chief Executive Officer of Ekso Bionics. "Through our virtual selling approach, we maintained a strong order pipeline by staying connected with our customer rehabilitation centers and network operators in delivering online service support and training. Operationally, at the start of the COVID-19 pandemic we took immediate actions to adjust our cost structure, enabling us to adapt to the new environment under these challenging market conditions. While the pandemic may impact the near-term outlook for the customers that we serve, we remain flexible both strategically and operationally to create long-term value for patients, customers, and our shareholders."

ShowHide Related Items >><<
EKSO Ekso Bionics
$7.36 /

-0.03 (-0.41%)

EKSO Ekso Bionics
$7.36 /

-0.03 (-0.41%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$7.36 /

-0.03 (-0.41%)

EKSO Ekso Bionics
$7.36 /

-0.03 (-0.41%)

Syndicate
Ekso Bionics files to sell 874K shares of common stock for holders  17:25
07/02/20
07/02
17:25
07/02/20
17:25
EKSO

Ekso Bionics

$7.35 /

+0.04 (+0.55%)

 
ShowHide Related Items >><<
EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

EKSO Ekso Bionics
$7.35 /

+0.04 (+0.55%)

On The Fly
Fly Intel: Pre-market Movers » 09:03
06/26/20
06/26
09:03
06/26/20
09:03
GPS

Gap

$10.17 /

-0.24 (-2.31%)

, ZGNX

Zogenix

$28.12 /

-0.22 (-0.78%)

, AXSM

Axsome Therapeutics

$76.66 /

+1.22 (+1.62%)

, EKSO

Ekso Bionics

$7.29 /

+4.18 (+134.41%)

, VXRT

Vaxart

$6.26 /

+3.08 (+96.86%)

, BIG

Big Lots

$33.83 /

+0.59 (+1.77%)

, NKE

Nike

$101.46 /

+1.37 (+1.37%)

, APOG

Apogee Enterprises

$22.52 /

+1.19 (+5.58%)

, DBVT

DBV Technologies

$5.40 /

-0.04 (-0.74%)

, SOLY

Soliton

$11.82 /

-0.18 (-1.50%)

, IDEX

Ideanomics

$2.43 /

-0.68 (-21.86%)

Check out this morning's…

ShowHide Related Items >><<
ZGNX Zogenix
$28.12 /

-0.22 (-0.78%)

VXRT Vaxart
$6.26 /

+3.08 (+96.86%)

SOLY Soliton
$11.82 /

-0.18 (-1.50%)

NKE Nike
$101.46 /

+1.37 (+1.37%)

IDEX Ideanomics
$2.43 /

-0.68 (-21.86%)

GPS Gap
$10.17 /

-0.24 (-2.31%)

EKSO Ekso Bionics
$7.29 /

+4.18 (+134.41%)

DBVT DBV Technologies
$5.40 /

-0.04 (-0.74%)

BIG Big Lots
$33.83 /

+0.59 (+1.77%)

AXSM Axsome Therapeutics
$76.66 /

+1.22 (+1.62%)

APOG Apogee Enterprises
$22.52 /

+1.19 (+5.58%)

GPS Gap
$10.17 /

-0.24 (-2.31%)

06/22/20 Wells Fargo
Gap rallies after Wells double upgrade on 'compelling value unlocks'
06/08/20 Deutsche Bank
Gap price target lowered to $13 from $15 at Deutsche Bank
06/05/20 MKM Partners
Gap price target raised to $12 from $8 at MKM Partners
06/05/20 RBC Capital
Gap price target raised to $13 from $8 at RBC Capital
ZGNX Zogenix
$28.12 /

-0.22 (-0.78%)

06/26/20 Stifel
FDA approval of Fintepla provides 'sigh of relief' for Zogenix, says Stifel
05/05/20 Piper Sandler
Zogenix price target lowered to $56 from $64 at Piper Sandler
04/22/20 Piper Sandler
Zogenix Fintepla data supports broader utility, says Piper Sandler
04/01/20 Mizuho
Zogenix price target lowered to $64 from $71 at Mizuho
AXSM Axsome Therapeutics
$76.66 /

+1.22 (+1.62%)

04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 Truist
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
04/28/20 H.C. Wainwright
Axsome Therapeutics price target raised to $210 from $200 at H.C. Wainwright
EKSO Ekso Bionics
$7.29 /

+4.18 (+134.41%)

06/26/20 H.C. Wainwright
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright
01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
VXRT Vaxart
$6.26 /

+3.08 (+96.86%)

04/30/20 H.C. Wainwright
Vaxart price target raised to $7 from $3 at H.C. Wainwright
08/15/19 Brookline
Vaxart initiated with a Buy at Brookline
06/27/19 H.C. Wainwright
Vaxart initiated with a Buy at H.C. Wainwright
BIG Big Lots
$33.83 /

+0.59 (+1.77%)

06/17/20 Piper Sandler
Piper boosts Big Lots estimates to Street-high, sees 'considerable upside'
05/26/20 Deutsche Bank
Big Lots price target raised to $31 from $19 at Deutsche Bank
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Big Lots initiated with a Neutral at Goldman Sachs
NKE Nike
$101.46 /

+1.37 (+1.37%)

06/26/20 Morgan Stanley
Market understands Nike's near-term challenges, says Morgan Stanley
06/26/20 Credit Suisse
Nike price target lowered to $111 from $114 at Credit Suisse
06/26/20 UBS
Nike price target raised to $127 from $122 at UBS
06/26/20 Citi
Nike disappointments offset by quarter-to-date performance, says Citi
APOG Apogee Enterprises
$22.52 /

+1.19 (+5.58%)

04/03/20 DA Davidson
Apogee Enterprises price target lowered to $22 from $35 at DA Davidson
12/20/19 DA Davidson
Apogee Enterprises price target lowered to $35 from $40 at DA Davidson
06/28/19 Craig-Hallum
Apogee Enterprises price target raised to $52 after Q1 report at Craig-Hallum
DBVT DBV Technologies
$5.40 /

-0.04 (-0.74%)

06/26/20 Stifel
DBV restructuring 'not comforting for investors,' says Stifel
04/06/20 Citi
DBV's Viaskin Peanut more likely than not to be approved, says Citi
03/23/20 Citi
Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak
03/20/20 Kepler Cheuvreux
DBV Technologies downgraded to Hold from Buy at Kepler Cheuvreux
SOLY Soliton
$11.82 /

-0.18 (-1.50%)

06/16/20 Roth Capital
Soliton price target raised to $16 from $14 at Roth Capital
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 Roth Capital
Soliton initiated with a Buy at Roth Capital
12/05/19 Maxim
Soliton initiated with a Buy at Maxim
IDEX Ideanomics
$2.43 /

-0.68 (-21.86%)

ZGNX Zogenix
$28.12 /

-0.22 (-0.78%)

SOLY Soliton
$11.82 /

-0.18 (-1.50%)

NKE Nike
$101.46 /

+1.37 (+1.37%)

GPS Gap
$10.17 /

-0.24 (-2.31%)

EKSO Ekso Bionics
$7.29 /

+4.18 (+134.41%)

DBVT DBV Technologies
$5.40 /

-0.04 (-0.74%)

BIG Big Lots
$33.83 /

+0.59 (+1.77%)

AXSM Axsome Therapeutics
$76.66 /

+1.22 (+1.62%)

APOG Apogee Enterprises
$22.52 /

+1.19 (+5.58%)

  • 26
    Jun
  • 04
    Mar
  • 30
    Jan
  • 19
    Dec
  • 09
    Oct
ZGNX Zogenix
$28.12 /

-0.22 (-0.78%)

VXRT Vaxart
$6.26 /

+3.08 (+96.86%)

NKE Nike
$101.46 /

+1.37 (+1.37%)

IDEX Ideanomics
$2.43 /

-0.68 (-21.86%)

GPS Gap
$10.17 /

-0.24 (-2.31%)

ZGNX Zogenix
$28.12 /

-0.22 (-0.78%)

VXRT Vaxart
$6.26 /

+3.08 (+96.86%)

NKE Nike
$101.46 /

+1.37 (+1.37%)

IDEX Ideanomics
$2.43 /

-0.68 (-21.86%)

GPS Gap
$10.17 /

-0.24 (-2.31%)

DBVT DBV Technologies
$5.40 /

-0.04 (-0.74%)

BIG Big Lots
$33.83 /

+0.59 (+1.77%)

AXSM Axsome Therapeutics
$76.66 /

+1.22 (+1.62%)

ZGNX Zogenix
$28.12 /

-0.22 (-0.78%)

NKE Nike
$101.46 /

+1.37 (+1.37%)

IDEX Ideanomics
$2.43 /

-0.68 (-21.86%)

GPS Gap
$10.17 /

-0.24 (-2.31%)

BIG Big Lots
$33.83 /

+0.59 (+1.77%)

AXSM Axsome Therapeutics
$76.66 /

+1.22 (+1.62%)

Recommendations
Ekso Bionics price target raised to $12 from $8 at H.C. Wainwright » 06:19
06/26/20
06/26
06:19
06/26/20
06:19
EKSO

Ekso Bionics

$7.29 /

+4.18 (+134.41%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Swayampakula Ramakanth raised the firm's price target on Ekso Bionics to $12 from $8 and reiterates a Buy rating on the shares after the company received 501(k) clearance from the FDA to market its lead product, EksoNR robotic exoskeleton, for the treatment of patients with acquired brain injuries. The analyst believes that the addition of new indication bodes well for a stronger adoption and to treat a broader group of patients.

ShowHide Related Items >><<
EKSO Ekso Bionics
$7.29 /

+4.18 (+134.41%)

EKSO Ekso Bionics
$7.29 /

+4.18 (+134.41%)

01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$7.29 /

+4.18 (+134.41%)

Hot Stocks
Ekso Bionics receives FDA clearance to market EksoNR robotic exoskeleton » 08:37
06/25/20
06/25
08:37
06/25/20
08:37
EKSO

Ekso Bionics

$3.11 /

-0.28 (-8.26%)

Ekso Bionics announced it…

Ekso Bionics announced it has received 501(k) clearance from the U.S. Food and Drug Administration to market its EksoNR robotic exoskeleton for use with patients with acquired brain injury. EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use with ABI, significantly expanding the device's indication to a broader group of patients. EksoNR is the next generation device of the most clinically used robotic exoskeleton, and was previously cleared by the FDA for stroke and spinal cord injury rehabilitation in 2016. The device was the first of its kind to receive a stroke indication and is now also the first to receive an ABI indication. EksoNR is cleared by the FDA for stroke, spinal cord injury, and acquired brain injury rehabilitation. The device is also CE-marked and available in Europe.

ShowHide Related Items >><<
EKSO Ekso Bionics
$3.11 /

-0.28 (-8.26%)

EKSO Ekso Bionics
$3.11 /

-0.28 (-8.26%)

01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$3.11 /

-0.28 (-8.26%)

Syndicate
Ekso Bionics files $75M mixed securities shelf  09:35
06/16/20
06/16
09:35
06/16/20
09:35
EKSO

Ekso Bionics

$3.77 /

+0.24 (+6.80%)

 
ShowHide Related Items >><<
EKSO Ekso Bionics
$3.77 /

+0.24 (+6.80%)

EKSO Ekso Bionics
$3.77 /

+0.24 (+6.80%)

01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$3.77 /

+0.24 (+6.80%)

Syndicate
Ekso Bionics announces closing of $7.89M registered direct offering » 13:34
06/10/20
06/10
13:34
06/10/20
13:34
EKSO

Ekso Bionics

$3.81 /

-0.15 (-3.79%)

Ekso Bionics Holdings…

Ekso Bionics Holdings announced the closing of its previously announced registered direct offering of 1,747,704 shares of its common stock at a purchase price of $4.5145 per share and the concurrent private placement of warrants to purchase up to 873,852 shares of its common stock issued to the accredited investors in the registered direct offering priced at-the-market under Nasdaq Rules, for aggregate gross proceeds of approximately $7.89M. The warrants are immediately exercisable, have an exercise price of $5.18 per share and a term of five and one-half years from the issuance date. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The company intends to use the net proceeds from the offering for working capital and general corporate purposes.

ShowHide Related Items >><<
EKSO Ekso Bionics
$3.81 /

-0.15 (-3.79%)

EKSO Ekso Bionics
$3.81 /

-0.15 (-3.79%)

01/10/20 H.C. Wainwright
Ekso's Q4 pre-announcement 'bodes well' for 2020 growth, says H.C. Wainwright
10/28/19 H.C. Wainwright
Ekso Bionics initiated with a Buy at H.C. Wainwright
09/06/19 Cantor Fitzgerald
Ekso Bionics initiated with an Overweight at Cantor Fitzgerald
EKSO Ekso Bionics
$3.81 /

-0.15 (-3.79%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.